How Companion Diagnostics Can Support Targeted Drug Launches

Coordinated development and practical testing pathways can help ensure eligible patients are identified from the point of approval

1

Precision medicine relies on the reliable delivery of diagnostics in routine practice to influence treatment decisions.
2

Companion diagnostics identify patients likely to benefit from targeted therapies, but slow adoption can lead to suboptimal treatment.
3

Community hospitals face significant barriers in implementing next-generation sequencing compared to academic centers, affecting patient access.
4

Turnaround time for diagnostic results is critical; delays can prevent patients from receiving timely, matched therapies.
5

Collaboration between pharmaceutical and diagnostics companies is essential for effective co-development and timely market access.

1